DrugPatentWatch Database Preview
United Therap Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for UNITED THERAP, and when can generic versions of UNITED THERAP drugs launch?
UNITED THERAP has four approved drugs.
There are twenty-one US patents protecting UNITED THERAP drugs.
There are ninety-nine patent family members on UNITED THERAP drugs in nine countries.
Summary for United Therap
| International Patents: | 99 |
| US Patents: | 21 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 4 |
| Patent Litigation for United Therap: | See patent lawsuits for United Therap |
| PTAB Cases with United Therap as patent owner: | See PTAB cases with United Therap as patent owner |
Drugs and US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | RX | Yes | No | 9,604,901 | Start Trial | Y | Start Trial | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-005 | Oct 7, 2016 | RX | Yes | No | 9,593,066 | Start Trial | Y | Start Trial | |||
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-003 | May 21, 2002 | AP | RX | Yes | Yes | 8,653,137 | Start Trial | Start Trial | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | RX | Yes | Yes | 9,393,203 | Start Trial | Y | Start Trial | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | RX | Yes | No | 8,410,169 | Start Trial | Y | Start Trial | |||
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-005 | Oct 7, 2016 | RX | Yes | No | 8,747,897 | Start Trial | Y | Start Trial | |||
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-004 | May 21, 2002 | AP | RX | Yes | Yes | 9,713,599 | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for United Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | 5,153,222 | Start Trial |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | 6,765,117 | Start Trial |
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-001 | May 21, 2002 | 5,153,222 | Start Trial |
| United Therap | TYVASO | treprostinil | SOLUTION;INHALATION | 022387-001 | Jul 30, 2009 | 6,521,212 | Start Trial |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-004 | Dec 20, 2013 | 6,765,117 | Start Trial |
| United Therap | REMODULIN | treprostinil | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | 021272-003 | May 21, 2002 | 5,153,222 | Start Trial |
| United Therap | ORENITRAM | treprostinil diolamine | TABLET, EXTENDED RELEASE;ORAL | 203496-003 | Dec 20, 2013 | 5,153,222 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for UNITED THERAP drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 10 mg/mL, 20 mL vial | ➤ Subscribe | 2011-12-02 |
| ➤ Subscribe | Inhalation Solution | 0.6 mg/mL, 2.9 mL ampules | ➤ Subscribe | 2015-04-13 |
| ➤ Subscribe | Extended-release Tablets | 0.25 mg and 1 mg | ➤ Subscribe | 2016-05-19 |
| ➤ Subscribe | Injection | 1 mg/mL, 2.5 mg/mL, and 5 mg/mL, 20 mL vial | ➤ Subscribe | 2012-12-07 |
| ➤ Subscribe | Extended-release Tablets | 2.5 mg | ➤ Subscribe | 2015-12-24 |
International Patents for United Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2010538092 | Start Trial |
| Canada | 2649243 | Start Trial |
| China | 101780092 | Start Trial |
| Japan | 2007514750 | Start Trial |
| Canada | 2851309 | Start Trial |
| Japan | 2018016653 | Start Trial |
| Japan | 2014114269 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
